Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05757011
Other study ID # FMASU MD 247/2020
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 5, 2020
Est. completion date August 10, 2023

Study information

Verified date March 2023
Source Ain Shams University
Contact Rana M Wagdy, Lecturer
Phone 01011431780
Email Ranawagdy5@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

40 patients who are consenting to be recruited in the study and are fulfilling the eligibility criteria will be subjected to: Group A Before the removal of uterus and the closure of vaginal cuff, insertion of 6inch 22G needle 2 to 3 cm below the umbilicus, 30 ml normal saline (sodium chloride solution 0.9%, FIPCO, Egypt)will be administered. While patients randomized to group B will undergo TLH with pre-sacral nerve block.


Description:

40 patients who are consenting to be recruited in the study and are fulfilling the eligibility criteria will be subjected to: Group A Before the removal of uterus and the closure of vaginal cuff, insertion of 6inch 22G needle 2 to 3 cm below the umbilicus, 30 ml normal saline (sodium chloride solution 0.9%, FIPCO, Egypt)will be administered , then the uterus will be removed, and the operation will be terminated While patients randomized to group B will undergo TLH with pre-sacral nerve block as follows: Uterosacral nerve block will be performed before the removal of uterus and the closure of vaginal cuff, and before the removal of trocars from abdominal cavity, insertion of 6-inch 22G needle 2 to 3 cm below the umbilicus, injection of the SHP area which situated anterior to L5-S1 vertebral bodies, Caudal to the bifurcation of the abdominal aorta with 30 ml 0.25% bupivacaine (Marcaine®0.25% , Astra Zeneca, Egypt) will be administered. Following the injection of local anesthetic, patient will be placed from Trendelenburg position to horizontal position. The we will remove the uterus and trocars , and the operation will be terminated. Data will be recorded in a case report form (CRF) and statistical analysis will be done.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date August 10, 2023
Est. primary completion date July 10, 2023
Accepts healthy volunteers No
Gender Female
Age group 35 Years to 70 Years
Eligibility Inclusion Criteria: - Women undergoing elective total laparoscopic hysterectomy Body mass index less than 29 Kg/m2 Exclusion Criteria: - Previous presacral neurectomy - Concurrent surgical procedure other than salpingectomy and/or oophorectomy - Chronic narcotic consumption Inability to provide consent - Patients with contraindication to laparoscopic surgery (e.g. severe cardiopulmonary dysfunction). - Bleeding tendency (e.g. patient on anticoagulants, platelets disorders) - Intra-abdominal adhesions (due to previous abdominal surgery e.g. myomectomy)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
pre-sacral nerve block (bupivacaine injection into both uterosacral ligaments at the end of laparoscopic hysterectomy.
pre-sacral nerve block (bupivacaine injection into both uterosacral ligaments at the end of laparoscopic hysterectomy.

Locations

Country Name City State
Egypt Ain Shams university Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary ? Post-operative pain 1 hour after the procedure will be assessed by visual analogue scale (VAS). (range will be from zero (no pain) to 10 ? Post-operative pain 1 hour after the procedure will be assessed by visual analogue scale (VAS). (range will be from zero (no pain) to 10 1hour
See also
  Status Clinical Trial Phase
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Completed NCT02638688 - Measurement of Fibroid Volume and 2D, 3D US N/A
Not yet recruiting NCT02769325 - Atropine in Laparoscopic Gynaecological Surgery Phase 4
Active, not recruiting NCT01697566 - An Endometrial Cancer Chemoprevention Study of Metformin Phase 3
Recruiting NCT06388590 - Acupuncture for Chronic Pelvic Pain N/A
Withdrawn NCT04089852 - Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women Phase 2/Phase 3
Recruiting NCT03589352 - Women's Knowledges About Gynaecological Aftercare
Recruiting NCT04737473 - The Comparative Efficacy and Safety of Two General Anesthesia Protocols Consisting of Fentanyl Plus Propofol Plus Rococuronium Plus Isoflurane Versus Ketamime Plus Magnesium Sulphate Plus Lidocaine Plus Clonidine Plus Propofol Plus Rococuronium Plus Isoflurane for Gynaecology Surgery in Cameroon N/A
Completed NCT02274441 - Activity and Quality of Care Indicators' for a Sentinel Network Creation N/A
Completed NCT03805386 - Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery Phase 2/Phase 3
Completed NCT06324019 - Gynaecological Examination Gown and Patient Satisfaction N/A
Recruiting NCT06394752 - UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare the Intrauterine Pathology Detection Rate Between Standard of Care Hydrosonography, and a New Visual Saline Infusion Device Providing Direct Visualization of the Uterus. N/A
Completed NCT02800031 - IOTA Versus Pattern Recognition Method in Diagnosis of Ovarian Masses N/A